isobavachin has been researched along with allopurinol in 1 studies
Studies (isobavachin) | Trials (isobavachin) | Recent Studies (post-2010) (isobavachin) | Studies (allopurinol) | Trials (allopurinol) | Recent Studies (post-2010) (allopurinol) |
---|---|---|---|---|---|
12 | 0 | 8 | 15,096 | 743 | 3,363 |
Protein | Taxonomy | isobavachin (IC50) | allopurinol (IC50) |
---|---|---|---|
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | Rattus norvegicus (Norway rat) | 3.3765 | |
Xanthine dehydrogenase/oxidase | Homo sapiens (human) | 3.1861 | |
Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | 5.0758 | |
Histamine H3 receptor | Cavia porcellus (domestic guinea pig) | 8.69 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Chen, Y; Li, L; Li, Y; Liao, H; Lin, C; Luo, J; Pang, J; Tian, J; Tian, Y; Wu, T; Yang, Y; Zhang, Q; Zhang, S; Zhao, K; Zhao, Z; Zheng, F | 1 |
1 other study(ies) available for isobavachin and allopurinol
Article | Year |
---|---|
Pharmacological evaluation of a novel skeleton compound isobavachin (4',7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity.
Topics: Animals; Flavones; Kidney; Molecular Docking Simulation; Rats; Rats, Sprague-Dawley; Uric Acid; Xanthine Oxidase | 2023 |